DSM Offers to Buy Martek Biosciences for $1 Billion

DSM says it has agreed to acquire nutritional ingredients producer Martek Biosciences (Colombia, MD) for about $1 billion ($31.50/share) in an all cash transaction. The deal represents a premium of 35% to Martek’s closing share price on December 20. It is expected to be completed in the first of second quarter of 2011. Martek reported sales of about $450.0 million in its fiscal year 2010 ended October 31. DSM says the deal will be immediately accretive to earnings by about 15-30 euro cents/share, and is expected “to realize material revenue...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers